MaaT Pharma Email Format
Biotechnology ResearchAuvergne-rhône-alpes, France51-200 Employees
MaaT Pharma is a mid-sized biotechnology company based in Lyon, France, focused on developing gut microbiome–driven therapies to modulate the immune system and improve outcomes for cancer patients. Founded in 2014, it operates as a late-stage clinical company within the biotech sector. The organization aims to deliver high-diversity, standardized drug candidates built on pooling and co-cultivation approaches to harness the microbiome's influence on immune responses. It has been listed on Euronext Paris since 2021, reflecting its presence in the public market.